Beconase

Cellulitis, Asthma, Nasal Polyps + 10 more

Treatment

20 Active Studies for Beconase

What is Beconase

Beclomethasone dipropionate

The Generic name of this drug

Treatment Summary

Beclomethasone dipropionate is a steroid medication used to reduce inflammation and treat symptoms associated with asthma, allergies, and skin conditions. It is available in a pressurized metered-dose inhaler, dry powder inhaler, and aqueous nasal spray. Beclomethasone dipropionate is less irritating to the nasal mucosa and works longer than older corticosteroids, such as dexamethasone and prednisolone, when administered intranasally.

Beconase AQ

is the brand name

Beconase Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Beconase AQ

Beclomethasone dipropionate

1989

29

Effectiveness

How Beconase Affects Patients

Beclomethasone dipropionate is a drug used to treat conditions caused by inflammation, such as asthma, allergic rhinitis, and skin conditions. When taken as an inhalant, it can improve lung function, help with breathing, and reduce asthma symptoms. However, long-term use or large doses may affect the body's hormone system, reduce bone density, and interfere with growth, particularly in children. It also has the potential to weaken the immune system and increase the risk of developing infections.

How Beconase works in the body

Beclomethasone dipropionate is a corticosteroid that helps fight inflammation. It works by binding to the glucocorticoid receptors in cells and signals them to produce anti-inflammatory proteins. It also stops the production of pro-inflammatory proteins that cause chronic inflammation. Lastly, it helps to relax the DNA around the cells, preventing transcription factors from activating genes that cause inflammation.

When to interrupt dosage

The prescribed dosage of Beconase is contingent upon the diagnosed condition, such as Adrenal Cortex Hormones, Dermatosis and Nasal Polyps. The amount of dosage is contingent upon the delivery system (e.g. Aerosol, metered; Suspension - Nasal or Powder - Respiratory (inhalation)) indicated in the table beneath.

Condition

Dosage

Administration

Cellulitis

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Asthma

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Nasal Polyps

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Nasal Polyps

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Operation on nose

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Dermatosis

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Skin Diseases

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

corticosteroid responsive

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Hay Fever

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Sinusitis

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Rhinitis, Allergic

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Sinusitis

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Rhinitis, Vasomotor

, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation

, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Cream - Topical, Aerosol, metered; Suspension, Suspension, Aerosol, metered; Suspension - Nasal, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Warnings

Beconase has six contraindications and should not be employed concurrently with the conditions in the below table.

Beconase Contraindications

Condition

Risk Level

Notes

Cellulitis

Do Not Combine

Tuberculosis

Do Not Combine

Status Asthmaticus

Do Not Combine

infected skin lesions

Do Not Combine

Virus Diseases

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Beclomethasone Dipropionate may interact with Pulse Frequency

There are 20 known major drug interactions with Beconase.

Common Beconase Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Beclomethasone dipropionate.

Abetimus

Major

The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abetimus.

Beconase Toxicity & Overdose Risk

The toxic dose of beclometasone dipropionate in rats is greater than 3750mg/kg. Inhalation of high amounts of this drug over a short period can reduce the activity of the hypothalamus, pituitary gland, and adrenal glands. If beclometasone dipropionate is used excessively over a long period, it may cause adrenal suppression.

Beconase Novel Uses: Which Conditions Have a Clinical Trial Featuring Beconase?

A total of 252 active clinical trials are being conducted to assess the potential of Beconase in treating corticosteroid-responsive dermatoses, Chronic Obstructive Pulmonary Disease (COPD) and Perennial Allergic Rhinitis (PAR).

Condition

Clinical Trials

Trial Phases

Asthma

86 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Skin Diseases

0 Actively Recruiting

Nasal Polyps

4 Actively Recruiting

Not Applicable, Phase 4, Phase 2

corticosteroid responsive

0 Actively Recruiting

Hay Fever

0 Actively Recruiting

Sinusitis

0 Actively Recruiting

Cellulitis

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Operation on nose

0 Actively Recruiting

Dermatosis

0 Actively Recruiting

Rhinitis, Vasomotor

1 Actively Recruiting

Not Applicable

Sinusitis

5 Actively Recruiting

Early Phase 1, Phase 1, Phase 2

Nasal Polyps

0 Actively Recruiting

Beconase Reviews: What are patients saying about Beconase?

5

Patient Review

6/29/2009

Beconase for Inflammation of the Nose due to an Allergy

Though it's an older drug, this steroid is still effective for twelve hours. I imagine the patent running out has something to do with the lack of advertisement. Helps a ton with seasonal allergies and can also act as a light psycho-stimulant if taken orally (in pill form).

Patient Q&A Section about beconase

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Beconase the same as Nasonex?

"The side effects of Nasonex that are different from those of Beconase include coughing, muscle or joint pain, blood-tinged mucus/phlegm, and nosebleeds. The side effects of Beconase that are different from those of Nasonex include sneezing, runny nose, lightheadedness, unpleasant taste or smell, or itching or rash."

Answered by AI

What type of drug is Beconase?

"Beconase is a medication that belongs to a class of drugs called corticosteroids. These drugs are designed to be taken intranasally, which means they are meant to be inhaled through the nose."

Answered by AI

What is Beconase used to treat?

"The spray works by reducing the inflammation in your nose.

Beclometasone is a nasal spray used to treat the symptoms of allergic rhinitis, which is an inflammation of the inside of the nose. The spray works by reducing the inflammation in the nose."

Answered by AI

Has Beconase got a steroid in it?

"The active ingredient in Beconase is a corticosteroid. Corticosteroids quickly reduce inflammation and swelling in the nasal passage, which reduces the symptoms of hayfever, such as an itching or blocked nose."

Answered by AI

Clinical Trials for Beconase

Image of Cedars-Sinai Medical Center Otolaryngology Clinics in Los Angeles, United States.

Lavender Aromatherapy for Anxiety and Pain During Otolaryngologic Procedures

18+
All Sexes
Los Angeles, CA

The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The main questions it aims to answer are: * Does lavender aromatherapy help reduce anxiety and/or pain, and improve patient comfort during awake otolaryngologic procedures in the clinic? * Do patients subjectively find aromatherapy relaxing and/or beneficial during the procedure? Researchers will compare lavender aromatherapy to placebo (an odorless liquid) to see if lavender aromatherapy helps improve patient comfort during their awake procedure Participants will: * Have their scheduled procedure performed with lavender aromatherapy or placebo during the duration of the procedure * Take a short, less than 1 minute questionnaire both before and after the procedure, describing their levels of anxiety, pain and subjective impressions of the aromatherapy

Recruiting
Paid Trial

Cedars-Sinai Medical Center Otolaryngology Clinics

Ankona Ghosh, MD

Have you considered Beconase clinical trials?

We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.
Go to Trials

Have you considered Beconase clinical trials?

We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.
Go to Trials
Image of DARTNet Institute in Aurora, United States.

Inhaled Corticosteroids + Azithromycin for Asthma

13 - 75
All Sexes
Aurora, CO

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.

Phase 4
Recruiting

DARTNet Institute (+12 Sites)

Wilson D Pace, MD, FAAFP

Image of St. Paul's Hospital in Vancouver, Canada.

Salbutamol for Athletic Performance

18 - 55
All Sexes
Vancouver, Canada

β2-Agonists, commonly used to treat asthma, have also been used by athletes to enhance performance, leading to their ban by the International Olympic Committee in 1972. Research has shown non-asthmatics receive no benefit from these drugs at therapeutic dosages; however, many elite athletes still use them, and asthmatic athletes often win more Olympic medals. In some non-asthmatics, β2-agonists may improve breathing limitations during high intensity exercise, which may improve performance. Therefore, we aim to examine if there is a select group of non-asthmatic individuals who experience breathing limitations that may receive benefit from β2-agonists.

Waitlist Available
Paid Trial

St. Paul's Hospital

Jordan A Guenette, PhD

Image of Velocity Clinical Research, Mobile in Mobile, United States.

PF-07275315 for Asthma

18 - 70
All Sexes
Mobile, AL

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 18 to 70 years old * Have had moderate-to-severe asthma for at least 12 months that is not well controlled * Have been taking their regular maintenance treatment(s) for asthma over the last 12 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. We will compare the experiences of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants will be involved in this study for about 9.5 months. During this time, they will have 10 visits at the study clinic.

Phase 2
Recruiting

Velocity Clinical Research, Mobile (+10 Sites)

Pfizer CT.gov Call Center

Pfizer

Have you considered Beconase clinical trials?

We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.
Go to Trials